Cargando…
Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer
Drug delivery systems are used to improve the biopharmaceutical properties of curcumin. Our aim was to investigate the effect of a water-soluble ‘two in one’ polymer containing covalently bonded PEG and βCD moieties (βCPCD) on the solubility and bioavailability of curcumin and compare it to a polyme...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537279/ https://www.ncbi.nlm.nih.gov/pubmed/34684005 http://dx.doi.org/10.3390/pharmaceutics13101710 |
_version_ | 1784588212255064064 |
---|---|
author | Haimhoffer, Ádám Dossi, Eleftheria Béresová, Monika Bácskay, Ildikó Váradi, Judit Afsar, Ashfaq Rusznyák, Ágnes Vasvári, Gábor Fenyvesi, Ferenc |
author_facet | Haimhoffer, Ádám Dossi, Eleftheria Béresová, Monika Bácskay, Ildikó Váradi, Judit Afsar, Ashfaq Rusznyák, Ágnes Vasvári, Gábor Fenyvesi, Ferenc |
author_sort | Haimhoffer, Ádám |
collection | PubMed |
description | Drug delivery systems are used to improve the biopharmaceutical properties of curcumin. Our aim was to investigate the effect of a water-soluble ‘two in one’ polymer containing covalently bonded PEG and βCD moieties (βCPCD) on the solubility and bioavailability of curcumin and compare it to a polymeric β-cyclodextrin (βCDP) cross-linked with epichlorohydrin. Phase-solubility and dynamic light scattering (DLS) experiments showed that the solubility of curcumin increased significantly in 10 m/m % βCPCD and βCDP solutions, but βCPCD–curcumin particles had higher hydrodynamic volume. The formation of the βCPCD–curcumin complex in solution and sedimented phase was confirmed by NMR spectroscopy. Biocompatibility and permeability experiments were performed on Caco-2 cells. Polymers did not show cytotoxicity up to 10 m/m % and βCPCD significantly increased the permeability of curcumin. DLS measurements revealed that among the interaction of polymers with mucin, βCPCD formed bigger aggregates compared to βCDP. Curcumin complexes were lyophilized into capsules and structurally characterized by micro-CT spectroscopy. Drug release was tested in a pH 1.2 medium. Lyophilized complexes had a solid porous matrix and both βCPCD and βCDP showed rapid drug release. βCPCD provides an opportunity to create a swellable, mucoadhesive matrix system for oral drug delivery. |
format | Online Article Text |
id | pubmed-8537279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85372792021-10-24 Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer Haimhoffer, Ádám Dossi, Eleftheria Béresová, Monika Bácskay, Ildikó Váradi, Judit Afsar, Ashfaq Rusznyák, Ágnes Vasvári, Gábor Fenyvesi, Ferenc Pharmaceutics Article Drug delivery systems are used to improve the biopharmaceutical properties of curcumin. Our aim was to investigate the effect of a water-soluble ‘two in one’ polymer containing covalently bonded PEG and βCD moieties (βCPCD) on the solubility and bioavailability of curcumin and compare it to a polymeric β-cyclodextrin (βCDP) cross-linked with epichlorohydrin. Phase-solubility and dynamic light scattering (DLS) experiments showed that the solubility of curcumin increased significantly in 10 m/m % βCPCD and βCDP solutions, but βCPCD–curcumin particles had higher hydrodynamic volume. The formation of the βCPCD–curcumin complex in solution and sedimented phase was confirmed by NMR spectroscopy. Biocompatibility and permeability experiments were performed on Caco-2 cells. Polymers did not show cytotoxicity up to 10 m/m % and βCPCD significantly increased the permeability of curcumin. DLS measurements revealed that among the interaction of polymers with mucin, βCPCD formed bigger aggregates compared to βCDP. Curcumin complexes were lyophilized into capsules and structurally characterized by micro-CT spectroscopy. Drug release was tested in a pH 1.2 medium. Lyophilized complexes had a solid porous matrix and both βCPCD and βCDP showed rapid drug release. βCPCD provides an opportunity to create a swellable, mucoadhesive matrix system for oral drug delivery. MDPI 2021-10-16 /pmc/articles/PMC8537279/ /pubmed/34684005 http://dx.doi.org/10.3390/pharmaceutics13101710 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haimhoffer, Ádám Dossi, Eleftheria Béresová, Monika Bácskay, Ildikó Váradi, Judit Afsar, Ashfaq Rusznyák, Ágnes Vasvári, Gábor Fenyvesi, Ferenc Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title | Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title_full | Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title_fullStr | Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title_full_unstemmed | Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title_short | Preformulation Studies and Bioavailability Enhancement of Curcumin with a ‘Two in One’ PEG-β-Cyclodextrin Polymer |
title_sort | preformulation studies and bioavailability enhancement of curcumin with a ‘two in one’ peg-β-cyclodextrin polymer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537279/ https://www.ncbi.nlm.nih.gov/pubmed/34684005 http://dx.doi.org/10.3390/pharmaceutics13101710 |
work_keys_str_mv | AT haimhofferadam preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT dossieleftheria preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT beresovamonika preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT bacskayildiko preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT varadijudit preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT afsarashfaq preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT rusznyakagnes preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT vasvarigabor preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer AT fenyvesiferenc preformulationstudiesandbioavailabilityenhancementofcurcuminwithatwoinonepegbcyclodextrinpolymer |